1. Home
  2. 6-(2,6-dichlorophenyl)-2-(4-fluoro-3-methylanilino)-8-methylpyrido[2,3-d]pyrimidin-7-one

Contact Angene

Tel: +852 8191 6999

Email: [email protected]

Brc1cnc(nc1)C
Pyrimidine, 5-bromo-2-methyl-
CCCP1(=O)OP(=O)(CCC)OP(=O)(O1)CCC
1,3,5,2,4,6-Trioxatriphosphorinane, 2,4,6-tripropyl-, 2,4,6-trioxide
CC1(C)OB(OC1(C)C)B1OC(C(O1)(C)C)(C)C
2,2'-Bi-1,3,2-dioxaborolane, 4,4,4',4',5,5,5',5'-octamethyl-
O=C(C=Cc1ccccc1)C=Cc1ccccc1.O=C(C=Cc1ccccc1)C=Cc1ccccc1.O=C(C=Cc1ccccc1)C=Cc1ccccc1.[Pd].[Pd]
Tris(dibenzylideneacetone)dipalladium
C1CCC(CC1)P(C1CCCCC1)C1CCCCC1.Cc1cc(C)c(c(c1)C)N1CCN(C1=[Ru](=Cc1ccccc1)(Cl)Cl)c1c(C)cc(cc1C)C
Ruthenium,[1,3-bis(2,4,6-trimethylphenyl)-2-imidazolidinylidene]dichloro(phenylmethylene)(tricyclohexylphosphine)-, (SP-5-41)-

6-(2,6-dichlorophenyl)-2-(4-fluoro-3-methylanilino)-8-methylpyrido[2,3-d]pyrimidin-7-one

Clc1cccc(c1c1cc2cnc(nc2n(c1=O)C)Nc1ccc(c(c1)C)F)Cl Request for Quotation
Chemical Name: 6-(2,6-dichlorophenyl)-2-(4-fluoro-3-methylanilino)-8-methylpyrido[2,3-d]pyrimidin-7-one
CAS Number: 287204-45-9
Product Number: AG00BHWH(AGN-PC-0LPWDG)
Synonyms:
MDL No: MFCD10565929
Molecular Formula: C21H15Cl2FN4O
Molecular Weight: 429.2744

Identification/Properties

Computed Properties
Molecular Weight:
429.276g/mol
XLogP3:
5.4
Hydrogen Bond Donor Count:
1
Hydrogen Bond Acceptor Count:
5
Rotatable Bond Count:
3
Exact Mass:
428.061g/mol
Monoisotopic Mass:
428.061g/mol
Topological Polar Surface Area:
58.1A^2
Heavy Atom Count:
29
Formal Charge:
0
Complexity:
640
Isotope Atom Count:
0
Defined Atom Stereocenter Count:
0
Undefined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
Covalently-Bonded Unit Count:
1
Compound Is Canonicalized:
Yes

Safety Information

NMR Spectrum

Other Analytical Data

Request for Quotation

Customer Feedback

Chemical Structure


PD 180970 is a potent and selective inhibitor of cyclin-dependent kinases (CDKs). It has shown promising results in chemical synthesis as a key component in the development of CDK inhibitors for cancer treatment. Due to its ability to specifically target CDKs, PD 180970 plays a crucial role in blocking cell cycle progression and inhibiting the growth of cancer cells, making it a valuable tool in anti-cancer drug research. Additionally, its application in chemical synthesis extends to exploring its potential in combination therapies and studying the mechanism of action of CDK inhibitors. This compound opens up exciting possibilities for developing novel cancer treatments and advancing our understanding of cell cycle regulation.